0920-1011 Medical Chart Abstraction Short Form - CDC 29AUG2019

Emergency Epidemic Investigation Data Collections - Expedited Reviews (Y3Q4)

Appendix 2. Medical Chart Abstraction Short Form_update3

E-cigarette associated pulmonary illness

OMB: 0920-1011

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-1011

Exp. Date 01/31/2020


CDC Medical Record Abstraction Short Form for E-cigarette Investigation SHORT FORM

August 27, 2019

Page 1







Severe Pulmonary Disease Associated with E-cigarette Use Outbreak



MEDICAL CHART ABSTRACTION SHORT FORM (CDC)


August 27, 2019





Medical Chart Abstraction Short Form – Selected Variables


Demographics


Case number (de-identified):


Age:


Ethnicity

  • Hispanic or Latino

  • Not Hispanic or Latino



Race: (Select all that apply)

  • White

  • Black or African American

  • Asian

  • American Indian/Alaska Native

  • Native Hawaiian or Other Pacific Islander



Sex

  • Male

  • Female


History of Present Illness


Admitted to hospital

  • Yes

  • No


Date of admission or initial evaluation (if not admitted):


Discharge diagnosis:


Date of initial symptom onset: ___________


Symptom at admission

Yes

No

Don’t Know or Not Documented

Shortness of breath




Difficulty breathing




Chest pain




Chest pain, pleuritic




Cough (any)




If yes (cough), productive?




Wheezing




Hemoptysis (coughing blood)




Nausea




Vomiting




Diarrhea




Abdominal pain




Unexpected weight loss over past 3 months (specify amount):_____________




Subjective (i.e. reported) fevers




Chills/Rigors




Headache




Stiff neck




Sore throat




Runny nose




Sneezing




Nasal congestion




Muscle Aches/myalgia




Joint pain




Sweats




Rash




Red or draining eyes




Other symptoms: ______________

*If not admitted, symptoms at most recent evaluation


Past medical history:

Check all that apply:

  • Asthma

  • Emphysema/bronchitis (COPD)

  • Bronchiectasis

  • Hypersensitivity pneumonitis

  • Cystic Fibrosis

  • Other chronic lung disease, specify: _____________

  • Heart failure

  • History of myocardial infarction (heart attack)

  • Other cardiac diagnosis: __________

  • HIV/AIDS

  • Cancer, specify type ____________

  • Injection Drug Use

  • Other, specify type ___________



Vital Signs

Initial/first recorded temperature: _________ specify Fahrenheit/Celsius


Initial/first recorded heart rate:


Initial/first recorded respiratory rate:


Initial/first recorded systolic blood pressure:


Initial/first recorded diastolic blood pressure:


Initial/first recorded SpO2 on room air (pulse oximetry, %) :



Substance Use History

Tobacco Smoking Status (smoking of any combustible tobacco product, including cigarettes, cigars (regular cigars, little cigars, cigarillos), hookahs, roll-your-own cigarettes, pipes, and bidis)

  • current smoker

  • former smoker

  • never smoker

  • unknown


Vaping or e-cigarette use in past 90 days, includes using an electronic device (e.g., electronic nicotine delivery system (ENDS), electronic cigarette, e-cigarette, vaporizer, vape(s), vape pen, dab pen, or other) or dabbing to inhale substances (e.g., nicotine, marijuana, THC, THC concentrates, CBD, synthetic cannabinoids, flavorings, or other substances).

  • current

  • former

  • never

  • unknown


Substances vaped (check all that apply)

  • Nicotine

  • Marijuana, THC, THC concentrates, hash oil, wax

  • Dank vapes

  • Synthetic cannabinoids (e.g., K2 or Spice)

  • CBD or CBD oil

  • Flavors

  • Other ___________

  • Not documented


Combustible Marijuana Smoking status (does not include vaping or dabbing, see above; only include use of smoked marijuana (e.g., joint, pipe, bong; sometimes called cannabis, pot, weed, hashish, grass))

  • current

  • former

  • never

  • unknown


Combustible Synthetic Cannabinoids Smoking status (does not include vaping or dabbing, see above; only include use of synthetic cannabinoids (e.g. K2, Spice))

  • current

  • former

  • never

  • unknown


Other substances inhaled:

  • Cocaine (crack)

  • Methamphetamine

  • Heroin

  • Huffing (paint, glue, bath salts)

  • Other_______________



Selected laboratory testing:

Admission sodium (Na):

Chloride (Cl):

Admission potassium (K):

Admission magnesium (Mg):

Admission blood urea nitrogen (BUN):

Admission creatinine:

Admission bicarbonate (CO2):


Admission Complete Blood Count:

White blood cells (WBC): ____________

WBC differential

% Neutrophils:

% Lymphocytes:

% Eosinophils:

% Monocytes:

% Basophils:

Hemoglobin:

Hematocrit:

Platelets:

Highest ALT (U/L):

Highest AST (U/L):

Admission total bilirubin:

Admission C-reactive protein (CRP):

Admission arterial blood gas (ABG) prior to mechanical ventilation:

pH: _____

pO2: _____

pCO2: _____

bicarbonate (HCO3): ______

pulse oximetry O2 saturation (at the time of the ABG draw): ______



Special laboratory testing:

Indicate any positive laboratory tests for infectious, rheumatologic, hypersensitivity panel

(See long form medical abstraction form for detailed examples of these tests)


Test

Date of collection

Results


















Imaging, medical procedures, and treatment:


Chest radiograph (x-ray) performed

□ Yes □ No □ Unknown


Initial chest radiograph (x-ray) findings:


Subsequent chest radiograph (x-ray) performed?

□ Yes □ No □ Unknown


Subsequent chest radiograph (x-ray) findings:


Chest CT (computed tomography) performed □ Yes □ No □ Unknown

Initial chest CT findings:


Bronchoscopy performed □ Yes □ No □ Unknown

Bronchoscopy findings:


Lung biopsy performed

□ Yes □ No □ Unknown


Lung biopsy findings:



Antimicrobials administered:

□ Yes □ No □ Unknown


Antimicrobials (e.g., antibiotics, antifungals, antivirals) administered. List all.

Antimicrobial name







Documented clinical response to antimicrobials:

□ Improvement

□ No change

□ Worsening clinical status

□ Unknown/not documented



Steroids administered:

□ Yes □ No □ Unknown


Steroid medication name

Route

Dose

Frequency






















Documented clinical response to steroids:

□ Improvement

□ No change

□ Worsening clinical status

□ Unknown/not documented



Required the following care:

Intensive care unit (ICU) admission □ Yes □ No □ Unknown

Ventilatory support with CPAP or BiPAP □ Yes □ No □ Unknown

Mechanical ventilation via endotracheal or tracheal intubation □ Yes □ No □ Unknown

Diagnosis of Acute Respiratory Distress Syndrome (ARDS) □ Yes □ No □ Unknown

Placed on extracorporeal membrane oxygenation (ECMO) □ Yes □ No □ Unknown



Outcomes

Died? □ Yes □ No □ Unknown

Date of death (MM/DD/YYYY): _________

Cause of death: ____________

Autopsy performed? □ Yes □ No □ Unknown

Report available? □ Yes □ No □ Unknown

Autopsy findings: __________


Case status

  • Confirmed

  • Probable

  • Not yet determined

  • Not a case

Public reporting burden of this collection of information is estimated to average 60 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorEvans, Mary (Molly) (CDC/DDNID/NCIPC/DUIP)
File Modified0000-00-00
File Created2021-01-15

© 2024 OMB.report | Privacy Policy